2 Firms To Lead Investor Suit Over Myovant-Sumitomo Deal
By Katryna Perera ( October 11, 2023, 2:43 PM EDT) -- Two firms have been named lead counsel for a proposed class action against Myovant Sciences Ltd. and Sumitomo Pharma America Inc. claiming lawyers from Skadden Arps Slate Meagher & Flom LLP who helped negotiate a merger between the pharmaceutical companies had undisclosed conflicts that resulted in a low-value deal, causing losses to Myovant minority shareholders....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.